Copyright
©The Author(s) 2017.
World J Gastroenterol. Oct 21, 2017; 23(39): 7139-7149
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7139
Published online Oct 21, 2017. doi: 10.3748/wjg.v23.i39.7139
Test | Items and interpretation |
Bath Ankylosing Spondylitis Disease Index[10] | 6 items: (1) fatigue, (2) back pain, (3) peripheral pain/swelling, (4) discomfort at pressure, (5) morning discomfort, and (6) duration of morning stiffness; |
Range from 0 to 10, with lower number representing less severe disease activity; | |
Score > 4 = active disease. | |
Ankylosing Spondylitis Disease Activity Score-C-Reactive Protein[11] | 5 items: (1) back pain, (2) morning stiffness, (3) patient global, (4) peripheral pain/swelling, and (5) C-reactive protein; |
Score < 1.3 = inactive disease; Score 1.3 to < 2.1 = moderate activity; Score 2.1 to ≤ 3.5 = high activity; Score > 3.5 = very high activit; Change ≥ 1.1 = clinically important improvement; Change ≥ 2.0 = major improvement. | |
Crohn’s Disease Activity Index[12] | 8 items: (1) liquid stools, (2) abdominal pain, (3) general well-being, (4) extra-intestinal manifestations (including arthralgia), (5) use of anti-diarrheals, (6) abdominal masses, and (7) hematocrit, 8) weight; |
Final score is the sum of items, weighted by different factors; | |
Score < 150 = non-active disease; Score > 150 = active disease; Score > 450 = extremely severe disease. | |
Partial MAYO score[13] | 3 items: (1) stool frequency, (2) rectal bleeding, and (3) physician global assessment; |
Range from 0 to 9; | |
Score < 2 = disease remission; Score 2-4 = mild disease activity; Score 5-7 = moderate disease activity; Score > 7 = severe disease activity. | |
Bath Ankylosing Spondylitis Functional Index[14] | 10 questions designed to determine the degree of functional limitation; |
Final score ranges from 0 to 10, with lower score indicating less functional limitation. | |
Inflammatory Bowel Disease Questionnaire[15] | 32 questions divided into 4 subscales: (1) bowel symptoms (10 questions); (2) systemic symptoms, including sleep disorders and fatigue (5 questions); (3) emotional function, such as depression, aggression and irritation (12 questions); and (4) social function, meaning the ability to participate in social activities and to work (5 questions); |
The patient is invited to choose from 1 to 7 for every question; | |
Total score ranges from 32 to 224 points, with lower scores reflecting worse quality of life. | |
Patient Global Assessment (PtGA) | Collected on a numeric rating scale ranging from 0 to 10 for the question asking the patient: “Considering all the ways your disease affects you, how much do you think is active today?” |
Short Form-36 health survey[16] | Generic health status instrument with 8 domains: (1) physical function, (2) body pain, (3) role limitations–physical, (4) general health, (5) vitality, (6) social function, (7) role limitations–emotional, and (8) mental health; |
Greater scores reflect better health status; | |
Summarized in two summary scores defined as the (1) physical component score (Sf-36/PCS) and (2) mental component score (Sf-36/MCS). |
- Citation: Luchetti MM, Benfaremo D, Ciccia F, Bolognini L, Ciferri M, Farinelli A, Rossini M, Mosca P, Triolo G, Gabrielli A. Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study. World J Gastroenterol 2017; 23(39): 7139-7149
- URL: https://www.wjgnet.com/1007-9327/full/v23/i39/7139.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i39.7139